CRIS Current Research Information System

FAROLFI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.472
NA - Nord America 1.027
EU - Europa 622
SA - Sud America 106
AF - Africa 68
OC - Oceania 1
Totale 3.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.009
SG - Singapore 646
CN - Cina 399
HK - Hong Kong 171
IT - Italia 118
VN - Vietnam 108
DE - Germania 105
BR - Brasile 77
GB - Regno Unito 76
SE - Svezia 60
NL - Olanda 49
KR - Corea 48
IN - India 38
FI - Finlandia 36
FR - Francia 36
CI - Costa d'Avorio 32
IE - Irlanda 30
RU - Federazione Russa 30
ID - Indonesia 18
SC - Seychelles 16
AT - Austria 15
AR - Argentina 14
BG - Bulgaria 13
CH - Svizzera 13
JP - Giappone 12
BE - Belgio 11
ES - Italia 9
TG - Togo 9
CA - Canada 8
UA - Ucraina 8
ZA - Sudafrica 8
CL - Cile 6
JO - Giordania 6
MX - Messico 5
TH - Thailandia 5
BD - Bangladesh 4
CO - Colombia 4
EC - Ecuador 3
EE - Estonia 3
IQ - Iraq 3
IR - Iran 3
GR - Grecia 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 3.296
Salva come PNG Salva come JPEG
Città #
Singapore 444
Ashburn 194
Hong Kong 171
Hefei 125
Santa Clara 123
Chandler 70
Beijing 65
Boardman 60
Southend 55
Seoul 47
Fairfield 45
Ho Chi Minh City 40
Helsinki 33
Abidjan 32
Ann Arbor 32
Dublin 30
Dallas 26
Princeton 26
Hanoi 25
Los Angeles 25
Buffalo 22
Houston 22
Seattle 22
Rome 20
Wilmington 20
Woodbridge 18
Frankfurt am Main 17
Cambridge 16
Bengaluru 14
Falkenstein 14
Munich 14
Jakarta 13
Nuremberg 13
Redondo Beach 13
Sofia 13
Tokyo 12
Bern 10
Milan 10
Brussels 9
Lomé 9
New York 9
Shanghai 9
São Paulo 8
Vienna 8
Bologna 7
Düsseldorf 7
Guangzhou 7
London 7
Amman 6
Berlin 6
Brooklyn 6
Chicago 6
Denver 6
Des Moines 6
Jacksonville 6
Montescudo 6
Nanjing 6
Padova 6
Shijiazhuang 6
Turin 6
Bangkok 5
Da Nang 5
Phoenix 5
Tianjin 5
Barcelona 4
Boston 4
Dongguan 4
Genoa 4
Jinan 4
Lauterbourg 4
Mexico City 4
Rio de Janeiro 4
Salvador 4
Shenzhen 4
Stockholm 4
Westminster 4
Wuhan 4
Atlanta 3
Belo Horizonte 3
Belém 3
Bühl 3
Changsha 3
Falls Church 3
Florence 3
Fort Worth 3
Foshan 3
Haiphong 3
Harbin 3
Jiaxing 3
Montreal 3
Ningbo 3
Paris 3
Salt Lake City 3
Shenyang 3
Tongling 3
Toronto 3
Amsterdam 2
Baghdad 2
Bexley 2
Bogotá 2
Totale 2.240
Salva come PNG Salva come JPEG
Nome #
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 161
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 138
Early Detection of Cardiotoxicity in Chemotherapy-Treated Patients from Real-time 3D Echocardiography 137
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice 130
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations. 126
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 124
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients? 119
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 111
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 109
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 105
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 104
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 104
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients 102
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 99
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 95
Taxanes as a Risk Factor for Acute Adverse Reactions to Iodinated Contrast Media in Cancer Patients 94
Erratum to “Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life” [Eur J Cancer 69 (2016) 110–118] 85
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 84
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 74
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 63
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial 59
Hydroxychloroquine as Prophylaxis for COVID-19: A Review 53
Immunotherapy for prostate cancer: Where we are headed 48
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors 47
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 44
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 44
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? 43
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 43
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma 42
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer 40
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 39
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 39
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer 39
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 38
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 38
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 37
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations 36
Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics 35
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 35
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures 34
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 33
Ipilimumab in advanced melanoma: Reports of long-lasting responses 33
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 33
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 33
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact 32
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact 32
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors 32
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer 31
Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches 30
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients 30
Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing 27
Psychosocial issues in long-term survivors of testicular cancer 27
Sorafenib for the treatment of breast cancer 21
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma 12
null 2
Totale 3.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.832
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 4 0 6 15 5 5 8
2021/2022200 10 3 5 17 15 10 10 16 9 24 40 41
2022/2023283 23 37 8 37 20 24 10 12 66 7 16 23
2023/2024166 11 13 12 2 5 18 6 4 70 3 16 6
2024/20251.184 67 160 109 111 181 70 39 39 13 81 46 268
2025/20261.304 257 250 199 206 316 76 0 0 0 0 0 0
Totale 3.405